Ruth L. Co

1.9k total citations · 1 hit paper
21 papers, 1.5k citations indexed

About

Ruth L. Co is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ruth L. Co has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 20 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Ruth L. Co's work include Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (7 papers). Ruth L. Co is often cited by papers focused on Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (17 papers) and Liver Disease Diagnosis and Treatment (7 papers). Ruth L. Co collaborates with scholars based in United States and Taiwan. Ruth L. Co's co-authors include Myron J. Tong, Andrew Conrad, Lawrence M. Blatt, John G. McHutchison, Patrick J. Coleman, Miriam J. Alter, Shinn‐Jang Hwang, George Kuo, David Chien and Shou‐Dong Lee and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Ruth L. Co

21 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Outcomes after Transfusion-Associated Hepatitis C

1995 985 citations Myron J. Tong, Ruth L. Co et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth L. Co United States	14	1.4k	1.3k	141	105	53	21	1.5k
F. Tremolada Italy	19	1.6k 1.2×	1.6k 1.3×	89 0.6×	115 1.1×	67 1.3×	43	1.8k
Takeshi Sodeyama Japan	13	1.4k 1.0×	1.3k 1.0×	169 1.2×	123 1.2×	91 1.7×	42	1.7k
Sergi Ampurdanés Spain	18	1.5k 1.1×	1.5k 1.2×	164 1.2×	118 1.1×	69 1.3×	27	1.8k
Terryl J. Ortego United States	5	1.2k 0.9×	1.1k 0.9×	337 2.4×	71 0.7×	59 1.1×	5	1.5k
Q-L. Choo Netherlands	8	1.4k 1.0×	1.2k 1.0×	95 0.7×	89 0.8×	82 1.5×	10	1.5k
Rune Wejstål Sweden	23	1.9k 1.3×	1.8k 1.4×	260 1.8×	113 1.1×	40 0.8×	67	2.1k
Ming‐Yuh Hsieh Taiwan	25	1.9k 1.4×	1.8k 1.4×	206 1.5×	145 1.4×	81 1.5×	72	2.2k
Donato Bacca Italy	16	1.6k 1.2×	1.5k 1.2×	170 1.2×	107 1.0×	26 0.5×	32	1.7k
Janusz Cianciara Poland	12	1.4k 1.0×	1.3k 1.0×	79 0.6×	231 2.2×	48 0.9×	33	1.5k
R. Soffredini Italy	19	1.2k 0.9×	1.1k 0.9×	127 0.9×	87 0.8×	47 0.9×	63	1.3k

Countries citing papers authored by Ruth L. Co

Since Specialization

Citations

This map shows the geographic impact of Ruth L. Co's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth L. Co with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth L. Co more than expected).

Fields of papers citing papers by Ruth L. Co

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth L. Co. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth L. Co. The network helps show where Ruth L. Co may publish in the future.

Co-authorship network of co-authors of Ruth L. Co

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth L. Co. A scholar is included among the top collaborators of Ruth L. Co based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth L. Co. Ruth L. Co is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Li, Chung‐Pin, Myron J. Tong, Shinn‐Jang Hwang, et al.. (2000). Autoimmune cholangitis with features of autoimmune hepatitis: Successful treatment with immunosuppressive agents and ursodeoxycholic acid. Journal of Gastroenterology and Hepatology. 15(1). 95–98. 12 indexed citations

2.

Tong, Myron J., et al.. (1998). The Changes in Quantitative HCV RNA Titers During Interferon Alpha 2B Therapy in Patients With Chronic Hepatitis C Infection. The American Journal of Gastroenterology. 93(4). 601–605. 7 indexed citations

3.

Tong, Myron J., Lawrence M. Blatt, John G. McHutchison, Ruth L. Co, & Andrew Conrad. (1997). Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison. Hepatology. 26(6). 1640–1645. 108 indexed citations

4.

Hwang, Shinn‐Jang, et al.. (1996). AETIOPATHOGENESIS OF HEPATOCELLULAR CARCINOMA. Journal of Gastroenterology and Hepatology. 11(10). 949–954. 40 indexed citations

5.

Lee, Shou‐Dong, et al.. (1996). Comparison of three different hybridization assays in the quantitative measurement of serum hepatitis B virus DNA. Journal of Virological Methods. 62(2). 123–129. 22 indexed citations

6.

Hwang, Shinn‐Jang, Myron J. Tong, Eun Sook Ko, et al.. (1996). Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.. PubMed. 11(10). 949–54. 54 indexed citations

7.

Tong, Myron J., et al.. (1995). Clinical Outcomes after Transfusion-Associated Hepatitis C. New England Journal of Medicine. 332(22). 1463–1466. 985 indexed citations breakdown →

8.

Tong, Myron J., et al.. (1995). Evaluation of sexual transmission in patients with chronic hepatitis C infection. Clinical and Diagnostic Virology. 3(1). 39–47. 15 indexed citations

9.

Tong, Myron J., et al.. (1995). A pilot, open-labelled, phase II study using oral ribavirin in the treatment of patients with chronic active hepatitis B. Clinical and Diagnostic Virology. 3(4). 377–385. 3 indexed citations

10.

Tong, Myron J., Shou‐Dong Lee, Ruth L. Co, et al.. (1994). Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin. Journal of Gastroenterology and Hepatology. 9(6). 587–591. 45 indexed citations

11.

Tong, Myron J., et al.. (1994). Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma.. PubMed. 160(2). 133–8. 17 indexed citations

12.

Tong, Myron J., et al.. (1993). Risk factors for hepatitis C virus infection among health care personnel in a community hospital. American Journal of Infection Control. 21(4). 196–200. 96 indexed citations

13.

Tong, Myron J., et al.. (1993). Hepatitis A vaccination.. PubMed. 158(6). 602–5. 14 indexed citations

14.

Co, Ruth L., et al.. (1989). Lack of Response to Recombinant Hepatitis B Vaccine in Nonresponders to the Plasma Vaccine. Survey of Anesthesiology. 33(2). 113–113. 1 indexed citations

15.

Tong, Myron J., et al.. (1988). A Cost Comparison Analysis for Screening and Vaccination of Hospital Personnel with High- and Low-Prevalence Hepatitis B Virus Antibodies in California. Infection Control and Hospital Epidemiology. 9(2). 66–71. 1 indexed citations

16.

Tong, Myron J., et al.. (1988). A Cost Comparison Analysis for Screening and Vaccination of Hospital Personnel with High- and Low-Prevalence Hepatitis B Virus Antibodies in California. Infection Control and Hospital Epidemiology. 9(2). 66–71. 3 indexed citations

17.

Tong, Myron J., et al.. (1987). A Hepatitis B Vaccination Program in a Community Teaching Hospital. Infection Control. 8(3). 102–107. 19 indexed citations

18.

Tong, Myron J., Shirley Liu, & Ruth L. Co. (1987). Persistence of Serum Hepatitis B Virus Deoxyribonucleic Acid in Hepatitis B Surface Antigen-Positive Patients With Chronic Persistent Hepatitis Treated With Predhisone. Gastroenterology. 92(4). 862–866. 4 indexed citations

19.

Tong, Myron J., Richard E. Sampliner, Sugantha Govindarajan, & Ruth L. Co. (1987). Spontaneous reactivation of hepatitis B in Chinese patients with Hbsag-positive chronic active hepatitis. Hepatology. 7(4). 713–718. 39 indexed citations

20.

Tong, Myron J., et al.. (1984). Hepatitis B Virus Markers in the Foreign-Born Chinese Population of Los Angeles, California. The Journal of Infectious Diseases. 149(3). 475–475. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact